Inogen Inc (INGN)
| Market Cap | 152.60M-33.8% |
| Revenue (ttm) | 354.30M |
| Net Income | -24.59M |
| EPS | -0.92 |
| Shares Out | 26.54M |
| PE Ratio | n/a |
| Forward PE | -35.94 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,524 |
| Open | 5.79 |
| Previous Close | 5.82 |
| Day's Range | 5.74 - 5.79 |
| 52-Week Range | 5.04 - 9.13 |
| Beta | 1.50 |
| Analysts | Strong Buy |
| Price Target | 12.00(+108.70%) |
| Earnings Date | Nov 5, 2026 |
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$INGN stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in INGN holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by INGN's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
INGN Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New INGN patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to INGN from public contracts
Source: USAspending.gov
INGN Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from INGN’s recent data — informational, not investment advice